carfilzomib + lenalidomide and dexamethasone
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for carfilzomib + lenalidomide and dexamethasone, covering 2022-09-15 to 2022-09-15. Get the full timeline:
Most recent: Clinical Trial Update: Carfilzomib + Lenalidomide and Dexamethasone for BTK Inhibitors Relapsed-refractory or Intolerant MCL [Phase 2]